Atrial fibrillation: one more sporting inconvenience?

Costello O, West JB. Short-term reversibility of ultrastructural changes in pulmonary capillaries caused by stress failure. J Appl Physiol 1992; 73: 1150–8. [12] Kay JM, Edwards FR. Ultrastructure of the alveolar-capillary wall in mitral stenosis. J Pathol 1973; 111: 239–45. [13] Lee YS. Electron microscopic studies on the alveolar-capillary barrier in the patients of chronic pulmonary edema. Jpn Circ J 1979; 43: 945–54. [14] Kay JM, de Sa DJ, Mancer JF. Ultrastructure of lung in pulmonary veno-occlusive disease. Hum Path 1983; 14: 451–6. [15] Ryan JW, Ryan US, Schultz DR, Whitaker C, Chung A. Subcellular localization of pulmonary angiotensin converting enzyme (kinase II). Biochem J 1975; 146: 497–9. [16] Guazzi M, Marenzi G, Alimento M, Contini M, Agostoni P. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation 1997; 95: 1930–6. [17] Guazzi M, Agostoni P. Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane. Clin Sci 1999; 96: 17–22. [18] Ewert R, Wensel R, Bettmann M, et al. Ventilatory and diffusion abnormalities in long-term survivors after orthotopic heart transplantation. Chest 1999; 115: 1305–11. [19] Dimopoulou I, Tsintzas OK, Daganou M, Cokkinos DV, Tzelepis GE. Contribution of lung function to exercise capacity in patients with chronic heart failure. Respiration 1999; 66: 144–9. [20] Guazzi M, Pontone G, Brambilla R, Agostoni P, Reina G. Alveolar-capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure. Eur Heart J, 2002; 23: 467–76 doi:10.1053/euhj.2001.2803. Editorials 431